✓ Betaling met creditcard hersteld — veilige afrekening via Privacy Shield

Roko

✅ Diarrhea Symptom Relief
✅ Normalizes Bowel Function
✅ Alleviates Associated Symptoms
✅ Quick and Effective
✅ Enhanced Quality of Life

Roko contains Loperamide hydrochloride

Medisch beoordeeld door Morgan Ellis — Apotheekonderzoeker · 8 jaar ervaring  · Laatst beoordeeld: mei 2026

Versleutelde checkout
Crypto betaalt 10% minder
Discrete wereldwijde levering
1.400+ klanten · 50+ landen

Quick Answer — What is Roko?

Roko tablet contains loperamide hydrochloride 2 mg — an opioid-receptor agonist restricted to the gut wall that slows intestinal motility and relieves acute and chronic diarrhoea. Manufactured by Cipla, the standard dose is 4 mg initially followed by 2 mg after each loose stool, up to 16 mg in 24 hours. It reduces stool frequency and urgency without the central nervous system effects of other opioids.

Wat u krijgt bij MedsBase: WHO-GMP gecertificeerde fabrikant · Discrete verpakking · Wereldwijde verzending · 1.400+ geverifieerde klantbeoordelingen

📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.

Waarom bestellen bij MedsBase

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.

What Is Roko?

Roko is an antidiarrhoeal tablet containing loperamide hydrochloride 2 mg, geproduceerd door Cipla Ltd in India. Loperamide is a synthetic opioid-receptor agonist that acts specifically within the gut wall to slow intestinal motility and reduce stool frequency. Unlike older opioids (codeine, diphenoxylate), loperamide has essentially no central nervous system activity at therapeutic doses because it is actively excluded from the brain by the blood-brain barrier’s P-glycoprotein transporter.

This pharmacological targeting makes Roko uniquely suitable for controlling diarrhoea without the sedation, euphoria, respiratory depression or abuse potential associated with other opioids. It has been a mainstay antidiarrhoeal worldwide since its introduction in the 1970s and is on the WHO Model List of Essential Medicines.

Uses of Roko

  • Acute non-infective diarrhoea — sudden onset, usually self-limiting, caused by dietary indiscretion, viral gastroenteritis (after infectious symptoms resolve), or medication side effects.
  • Chronic diarrhoea — in irritable bowel syndrome with diarrhoea (IBS-D), inflammatory bowel disease during remission, post-vagotomy or short bowel syndrome.
  • Traveller’s diarrhoea — symptomatic relief in addition to appropriate rehydration.
  • Ileostomy output reduction — in patients with high-output stomas where fluid loss is problematic.
  • Radiation-induced diarrhoea — in patients undergoing pelvic radiotherapy.
  • Chemotherapy-induced diarrhoea — particularly with irinotecan-based regimens.

How Roko Works

Loperamide binds to μ-opioid receptors in the myenteric plexus of the large intestine — the network of nerve cells that regulates peristalsis. Binding inhibits release of acetylcholine and prostaglandins, which reduces the strength and frequency of intestinal contractions. The result is slower transit time, giving the colon more opportunity to reabsorb water and electrolytes from the stool. Net stool volume decreases and stools become firmer.

Loperamide also reduces anal sphincter tone abnormalities seen in diarrhoea, improving continence. At therapeutic doses, there is no analgesic or central opioid effect because of the P-glycoprotein efflux barrier at the blood-brain barrier. This is why loperamide is not classified as a controlled substance in most countries.

Dosering en toediening

Adult dose for acute diarrhoea: 4 mg (two tablets) initially, followed by 2 mg (one tablet) after each subsequent loose stool. Maximum 16 mg (8 tablets) in 24 hours. Discontinue when stools become formed.

Adult dose for chronic diarrhoea: 4 mg initially, then 2 mg after each loose stool or as needed. Maintenance dose 2–12 mg daily, adjusted to clinical response. Maximum 16 mg daily.

Children aged 4–8 years: 1 mg up to 3 times daily, maximum 2 days. Children 9–12 years: 2 mg twice daily, maximum 5 days. Do not use in children under 4 without medical advice.

How to Use Roko

  1. Take tablets whole with water. Roko does not need to be taken with food.
  2. Along with Roko, maintain good hydration — oral rehydration salts (ORS) are recommended to replace lost fluids and electrolytes.
  3. Stop taking Roko as soon as diarrhoea resolves or stools become formed. Do not continue prophylactically.
  4. Seek medical advice if diarrhoea does not improve within 48 hours, or if fever, bloody stool, or severe abdominal pain develop.
  5. Do not exceed 16 mg (8 tablets) in any 24-hour period.

Side Effects of Roko

  • Vaak voorkomend: constipation (especially with extended use); abdominal pain or cramps; bloating; nausea; dry mouth; dizziness.
  • Minder vaak voorkomend: skin rash; flatulence; vomiting; tiredness.
  • Zeldzaam maar ernstig: paralytic ileus (particularly with high doses or in young children); toxic megacolon in ulcerative colitis flare; allergic reactions including angioedema; severe constipation leading to bowel obstruction.
  • At extreme overdose (>60 mg): cardiac arrhythmia — QT prolongation, torsades de pointes — due to peripheral sodium channel blockade. This risk has led to regulatory limits on package sizes in several countries.

Precautions and Warnings

  • Bloody diarrhoea or high fever: DO NOT use Roko — these suggest invasive bacterial infection (Salmonella, Shigella, C. difficile) or colitis where slowing motility can worsen outcome.
  • Acute ulcerative colitis flare: contraindicated — risk of toxic megacolon.
  • Antibiotic-associated colitis (C. difficile): avoid — slowing motility traps toxins in the colon.
  • Children under 2 years: contraindicated — risk of paralytic ileus.
  • Ernstige leverfunctiestoornis: reduced metabolism — use with caution, lower doses.
  • Pregnancy: limited data; use only if benefits clearly outweigh risks.
  • Breastfeeding: small amounts excreted in breast milk — short courses are generally considered safe.

Geneesmiddelinteracties

Important interactions: ritonavir, quinidine, itraconazole, ketoconazole — inhibit loperamide metabolism and P-glycoprotein efflux, increasing plasma levels and risk of central opioid effects and cardiac toxicity; cholestyramine — binds loperamide in gut, reducing absorption; QT-verlengende geneesmiddelen (amiodarone, sotalol, macrolide antibiotics, some antipsychotics) — additive arrhythmia risk at high loperamide doses; other opioids — theoretical additive central effects at very high doses.

Opslag

Store below 25 °C in the original blister, protected from moisture. Keep out of reach of children. Do not use after the expiry date.

Veelgestelde vragen

How quickly does Roko work?

Relief typically begins within 30 minutes to 1 hour of the first 4 mg dose. Peak effect is at 4–5 hours. Most episodes of acute diarrhoea resolve within 24 hours of starting Roko, though chronic diarrhoea requires longer ongoing dosing adjusted to individual response.

Can I take Roko for traveller’s diarrhoea?

Yes — Roko is effective for symptomatic relief of traveller’s diarrhoea and can be combined with appropriate antibiotic therapy in moderate-to-severe cases. If bloody stool, high fever, or severe abdominal pain develop, seek medical care rather than self-treating with loperamide alone.

Is Roko safe for long-term use?

For chronic conditions such as IBS-D or ileostomy management, loperamide can be used long-term under medical supervision at the lowest effective dose. Monitor for constipation and adjust dose as needed. Long-term use at standard doses is not associated with dependence or tolerance.

Can I give Roko to my child?

Loperamide is not recommended for children under 2 years due to increased risk of paralytic ileus. For children 4–8 years, 1 mg doses can be given for short periods. Always consult a paediatrician first, and ensure adequate fluid intake with oral rehydration salts regardless of whether Roko is used.

Why is loperamide not addictive?

Loperamide is actively pumped out of the brain by P-glycoprotein at the blood-brain barrier. At therapeutic doses, effectively none reaches the central opioid receptors responsible for euphoria or dependence. At extremely high doses (>60 mg), the transporter saturates and some central effects can occur — which is why package-size limits have been introduced in several countries.

When should I NOT take Roko?

Do not take Roko if you have: bloody stool, high fever (over 38.5 °C), severe abdominal pain suggestive of ileus or peritonitis, antibiotic-associated colitis, or an active flare of ulcerative colitis or Crohn’s disease. In these situations, slowing motility can worsen the underlying condition.

What should I do if I accidentally took too much?

A modest overdose (up to 16 mg above the daily limit) usually only causes severe constipation or abdominal cramps. Large overdoses (above 60 mg in a day) can cause cardiac arrhythmia and require urgent medical attention — ECG monitoring and supportive care. If in doubt, call your poison control centre or seek emergency care.

Gerelateerde alternatieven

Andere producten in Algemene gezondheid die klanten ook bekijken:

Hoeveelheid

30 Capsule/s, 60 Capsule/s, 90 Capsule/s

Beoordelingen

Er zijn nog geen beoordelingen

Plaats een beoordeling
Roko Roko
Beoordeling*
0/5
* Beoordeling is verplicht
* Antwoord is verplicht
Jouw beoordeling
* Beoordeling is verplicht
Naam
* Naam is verplicht
Voeg foto's of video toe aan je beoordeling

Vragen & antwoorden

Stel een vraag
Roko Roko
Uw vraag
* Vraag is verplicht
Naam
* Naam is verplicht
Er zijn nog geen vragen